Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmen Tur

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
Neuroimage. Clinical|December 7, 2021
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS techniqueCarmen Tur, Francesco Grussu, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2024
What contributes to disability in progressive MS? A brain and cervical cord-matched quantitative MRI studyCarmen Tur, Marco Battiston, Marios C Yiannakas, et al.
Neurology|June 18, 2024
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple SclerosisOlga Ciccarelli, Frederik Barkhof, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosisÖzgür Yaldizli, Varun Sethi, Matteo Pardini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2015
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?Laura Negrotto, Carmen Tur, Mar Tintoré, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosisÖzgür Yaldizli, Varun Sethi, Matteo Pardini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 2025
MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation: a systematic review and meta-analysisVasilis-Spyridon Tseriotis, Georgina Arrambide, Edgar Carnero Contentti, et al.
Neurology|March 12, 2022
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple SclerosisAlberto Calvi, Ferran Prados Carrasco, Carmen Tur, et al.
Brain Communications|October 16, 2023
Genetic influences on disease course and severity, 30 years after a clinically isolated syndromeNitin Sahi, Lukas Haider, Karen Chung, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Neuroimage. Clinical|January 22, 2016
Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosisMarios C Yiannakas, Ahmed M Mustafa, Benjamin De Leener, et al.
Neuroimage. Clinical|December 7, 2021
Spatial patterns of brain lesions assessed through covariance estimations of lesional voxels in multiple Sclerosis: The SPACE-MS techniqueCarmen Tur, Francesco Grussu, Floriana De Angelis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 19, 2024
What contributes to disability in progressive MS? A brain and cervical cord-matched quantitative MRI studyCarmen Tur, Marco Battiston, Marios C Yiannakas, et al.
Neurology|June 18, 2024
Using the Progression Independent of Relapse Activity Framework to Unveil the Pathobiological Foundations of Multiple SclerosisOlga Ciccarelli, Frederik Barkhof, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|February 8, 2018
Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosisÖzgür Yaldizli, Varun Sethi, Matteo Pardini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 18, 2015
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?Laura Negrotto, Carmen Tur, Mar Tintoré, et al.
Multiple Sclerosis and Related Disorders|May 31, 2016
HLA-DRB*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosisÖzgür Yaldizli, Varun Sethi, Matteo Pardini, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 2025
MRI lesion distribution criteria for MS, NMOSD and MOGAD differentiation: a systematic review and meta-analysisVasilis-Spyridon Tseriotis, Georgina Arrambide, Edgar Carnero Contentti, et al.
Neurology|March 12, 2022
Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple SclerosisAlberto Calvi, Ferran Prados Carrasco, Carmen Tur, et al.
Brain Communications|October 16, 2023
Genetic influences on disease course and severity, 30 years after a clinically isolated syndromeNitin Sahi, Lukas Haider, Karen Chung, et al.
Pageof 15